SCHEMBL27346113

SCHEMBL27346113

FC(F)(F)CCCN1CCNCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 3/20 0.52
CHRM2 P08172 1/20 0.46
CHRM4 P08173 1/20 0.46
CHRM5 P08912 1/20 0.46
CHRM1 P11229 1/20 0.46
CHRM3 P20309 1/20 0.46
SIGMAR1 Q99720 2/20 0.44
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.42
KDM1A O60341 1/20 0.38
RAD52 P43351 1/20 0.36
GNAO1 P09471 4/20 0.36
HRH2 P25021 1/20 0.36
HRH1 P35367 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
GNAI3 P08754 3/20 0.34
GNAI1 P63096 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1899369 0.86 POLB (0.46) CXCR4CHRM2CHRM4CHRM5CHRM1
Hydrochloric Acid SCHEMBL6476236 0.84 POLB (0.45) CXCR4CHRM2CHRM4CHRM5CHRM1
Hydrochloric Acid SCHEMBL2013603 0.84 POLB (0.45) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL7588523 0.83 CXCR4 (0.48) CXCR4CHRM2CHRM4CHRM5CHRM1
Trifluoroacetic Acid SCHEMBL29384411 0.82 CXCR4 (0.43) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL8614873 0.80 CXCR4 (0.70) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL993010 0.80 CXCR4 (0.73) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL18572719 0.79 HRH3 (0.56) CXCR4CHRM2CHRM4CHRM5CHRM1
Potassium SCHEMBL30828934 0.78 POLB (0.41) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL27100241 0.78 POLB (0.41) CXCR4CHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217978-A1 COMPOUND AS ADENOSINE A2a RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2024-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240217978-A1 COMPOUND AS ADENOSINE A2a RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITION COMPRISING SAME ADORA2A, ADORA1, ADORA2B CXCR4 466/4885CHRM2 184/4885CHRM4 511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.